doi:10.3969/j.issn.1004-583X.2025.04.016

Abstract

CLC Number:

R459.5

Add to citation manager EndNote|Ris|BibTeX

URL: https://lchc.magtechjournal.com/EN/10.3969/j.issn.1004-583X.2025.04.016

https://lchc.magtechjournal.com/EN/Y2025/V40/I4/381

References 26

[1]	杨凡. 白细胞介素-6在腹膜透析相关并发症中的作用研究进展[J]. 临床肾脏病杂志, 2021, 21(6): 512-515.
[2]	Berke I, Barutcu Atas D, Tugcu M, et al. Clinical outcomes in peritoneal dialysis with refractory peritonitis: Significance of the day 5 cell count[J]. Clin Exp Nephrol, 2025, 29(2):221-226.
[3]	Ronquillo JG, Lester WT. Precision medicine landscape of genomic testing for patients with cancer in the national institutes of health all of us database using informatics approaches[J]. JCO Clin Cancer Inform, 2022, 6:e2100152.
[4]	Chen J, Zheng QY, Wang LM, et al. Proteomics reveals defective peroxisomal fatty acid oxidation during the progression of acute kidney injury and repair[J]. Heliyon, 2023, 9(7):e18134.
[5]	Wei L, Han Y, Tu C. Molecular pathways of diabetic kidney disease inferred from proteomics[J]. Diabetes Metab Syndr Obes, 2023, 16:117-128.
[6]	Sheela Devi C, et al. Vivian Joseph Ratnam P, Ramya SR, Detection of 16S rRNA gene for rapid identification of bacterial pathogens causing peritonitis in patients on continuous ambulatory peritoneal dialysis[J]. Indian J Med Microbiol, 2022, 40(3):409-412.
[7]	Tang X, Zheng W, Hu J, et al. Proteomics-based analysis of potential therapeutic targets in patients with peritoneal dialysis-associated peritonitis[J]. Biochim Biophys Acta Proteins Proteom, 2022, 1870(7):140796.
[8]	Fang J, Tong Y, Ji O, et al. Glycoprotein 96 in peritoneal dialysis effluent-derived extracellular vesicles: A tool for evaluating peritoneal transport properties and inflammatory status[J]. Front Immunol, 2022, 13:824278.
[9]	郑婕, 罗娟, 彭凤, 等. 腹膜透析患者不同腹膜转运功能与炎症因子、VEGF的相关性研究[J]. 检验医学与临床, 2022, 19(19):2617-2619.
[10]	马粜娟, 吴晓庆, 朱燕亭, 等. 腹膜功能障碍的评估及诊治进展[J]. 中国血液净化, 2022, 21(12):907-911.
[11]	Bao M, Sun Z, Yang X, et al. Orosomucoid can predict baseline peritoneal transport characteristics in peritoneal dialysis patients and reduce peritoneal proteins loss[J]. J Proteomics, 2021, 242:104260.
[12]	Ferrantelli E, Farhat K, Ederveen ALH, et al. Effluent and serum protein N-glycosylation is associated with inflammation and peritoneal membrane transport characteristics in peritoneal dialysis patients[J]. Sci Rep, 2018, 8(1):979. doi: 10.1038/s41598-018-19147-x pmid: 29343697
[13]	Kondou A, Begou O, Dotis J, et al. Impact of metabolomics technologies on the assessment of peritoneal membrane profiles in peritoneal dialysis patients: A systematic review[J]. Metabolites, 2022, 12(2): 145.
[14]	Ramil-Gómez O, López-Pardo M, Fernández-Rodríguez JA, et al. Involvement of mitochondrial dysfunction in the inflammatory response in human mesothelial cells from peritoneal dialysis effluent[J]. Antioxidants (Basel), 2022, 11(11):2184.
[15]	Zhang Y, Feng W, Peng X, et al. Parthenolide alleviates peritoneal fibrosis by inhibiting inflammation via the NF-κB/ TGF-β/Smad signaling axis[J]. Lab Invest, 2022, 102(12):1346-1354. doi: 10.1038/s41374-022-00834-3 pmid: 36307537
[16]	Jiang N, Zhang Q, Chau MK, et al. Anti-fibrotic effect of decorin in peritoneal dialysis and PD-associated peritonitis[J]. EBioMedicine, 2020,52:102661.
[17]	Huang SH, Hong ZJ, Chen MF, et al. Melatonin inhibits the formation of chemically induced experimental encapsulating peritoneal sclerosis through modulation of T cell differentiation by suppressing of NF-κB activation in dendritic cells[J]. Int Immunopharmacol, 2024,126:111300.
[18]	Guo Y, Wang L, Gou R, et al. Ameliorative role of SIRT1 in peritoneal fibrosis: An in vivo and in vitro study[J]. Cell Biosci, 2021, 11(1):79. doi: 10.1186/s13578-021-00591-8 pmid: 33906673
[19]	Mo M, Zeng Y, Zeng Y, et al. N-methylpiperazine-diepoxyovatodiolide ameliorates peritoneal fibrosis via suppressing TGF-β/Smad and JAK/STAT signaling pathway[J]. Chem Biol Interact, 2023, 382:110589.
[20]	Zhang J, Chen Y, Chen T, et al. Single-cell transcriptomics provides new insights into the role of fibroblasts during peritoneal fibrosis[J]. Clin Transl Med, 2021, 11(3):e321. doi: 10.1002/ctm2.321 pmid: 33784014
[21]	Huang Q, Sun Y, Peng L, et al. Extracellular vesicle-packaged ILK from mesothelial cells promotes fibroblast activation in peritoneal fibrosis[J]. J Extracell Vesicles, 2023, 12(7):e12334.
[22]	Kang Y, Liu Y, Fu P, et al. Peritoneal fibrosis:From pathophysiological mechanism to medicine[J]. Front Physiol, 2024, 15:1438952.
[23]	Li N, Fu J, Wang Q, et al. MiR-454-3p regulates high glucose-induced mesothelial-mesenchymal transition and glycolysis in peritoneal mesothelial cells by targeting STAT3[J]. Ren Fail, 2024, 46(2):2394635.
[24]	Han SM, Ryu HM, Suh J, et al. Network-based integrated analysis of omics data reveal novel players of TGF-β1-induced EMT in human peritoneal mesothelial cells[J]. Sci Rep, 2019, 9(1):1497. doi: 10.1038/s41598-018-37101-9 pmid: 30728376
[25]	姚玲, 邵小琪, 何萌萌, 等. Galectin-3在腹膜透析液中的表达及其临床意义研究[J]. 安徽医科大学学报, 2024, 59(5):889-893.
[26]	Evgeniou M, Sacnun JM, Kratochwill K, et al. A meta-analysis of human transcriptomics data in the context of peritoneal dialysis identifies novel receptor-ligand interactions as potential therapeutic targets[J]. Int J Mol Sci, 2021, 22(24):13277.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 26

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Lin Zexing, Guo Hancheng, Yao Chunmeng, Xiao Liangxiang, Dai Yunxin, Wu Sai, Wang Fuzhen, Xie Zugang, Yao Cuiwei. Study on influencing factors and prevention for the complications of the “pull technique” technique for peritoneal catheter extubationremoval and the prevention [J]. Clinical Focus, 2025, 40(1): 39-43.
[2]	Xu Ruoyun, Liu Qiong, Jia Minnan, Liu Bing. Maintenance peritoneal dialysis complicated with colon fistula and bladder fistula: A case report and literature review [J]. Clinical Focus, 2024, 39(11): 1016-1020.
[3]	Yang Haiyan, Chen Ling, Dai Bo, Liu Xia, Sun Shangping. Blood potassium fluctuations before and after dialysis in maintenance hemodialysis patients [J]. Clinical Focus, 2024, 39(9): 798-802.
[4]	. [J]. Clinical Focus, 2023, 38(12): 1150-1152.
[5]	Gong Zhiqing, Lu Dongmei, Xing Guangqun. The predictive and prognostic potential of serum parathyroid hormone combined with the nutritional status score on peritoneal dialysis catheter-related peritonitis [J]. Clinical Focus, 2023, 38(11): 991-995.
[6]	. [J]. Clinical Focus, 2023, 38(11): 1038-1041.
[7]	Li Hengnan, Huang Yan, Zhao Yajuan, Hu Guicai. Correlation between serum CTRP5 and left ventricular diastolic dysfunction in patients with continuous ambulatory peritoneal dialysis and its diagnostic value [J]. Clinical Focus, 2023, 38(4): 324-329.
[8]	Tao Yang, Pan Qingquan, Li Yan. Evaluation of hemoperfusion and continuous renal replacement therapy in paraquat poisoning patients complicated with MODS [J]. Clinical Focus, 2023, 38(4): 330-334.
[9]	Zhang Hongtao, Wang Zhikui. Renal anemia in patients with maintenance peritoneal dialysis and Related Factors: A single-center study [J]. Clinical Focus, 2022, 37(12): 1099-1103.
[10]	. [J]. Clinical Focus, 2022, 37(6): 556-559.
[11]	Cheng Huidong, Si Bolin, Hua Qin, He Jianqiang, Gui Lanlan. Efficacy comparison between pull and surgical technique for removal of peritoneal dialysis catheter [J]. Clinical Focus, 2021, 36(12): 1097-1101.
[12]	. [J]. Clinical Focus, 2021, 36(12): 1136-1138.
[13]	Shang Qihang, Chen Huaqian. Relationship between eosinophil levels and carotid atherosclerosis in maintenance hemodialysis patients [J]. Clinical Focus, 2021, 36(1): 44-48.
[14]	Shi Youshan, Chen Tianhao. Pathogenic bacteria and etiological analysis of peritoneal dialysisassociated peritonitis in a single peritoneal dialysis center [J]. Clinical Focus, 2020, 35(11): 1010-1014.
[15]	Duan Hailing;Cui Xiangqin;Wang Zongbao;Liu Guanbin;Geng Mingliang. Clinical application of vitamin E combined with hemoperfusion in maintenance hemodialysis patients [J]. Clinical Focus, 2015, 30(11): 1288-1291.